Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.58 SEK | -0.76% | +10.31% | +140.66% |
Apr. 23 | Moberg Pharma AB Announces Launch Update for Mob-015 | CI |
Apr. 08 | Moberg Pharma AB Submits Application to Include an Additional Terbinafine Supplier | CI |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 44 | 05-12-31 |
Mark Beveridge
DFI | Director of Finance/CFO | 46 | 14-12-31 |
Chief Tech/Sci/R&D Officer | 60 | 22-12-31 | |
Sales & Marketing | 62 | 19-01-07 | |
Annica Magnusson
LAW | General Counsel | 61 | 19-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Lundmark
BRD | Director/Board Member | 66 | 22-05-15 |
Håkan Wallin
BRD | Director/Board Member | 62 | 23-05-15 |
Nikolaj Sørensen
BRD | Director/Board Member | 52 | 20-12-31 |
Chairman | 64 | 22-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,407,452 | 19,288,290 ( 67.90 %) | 445,974 ( 1.570 %) | 67.90 % |
Company contact information
Moberg Pharma AB
Gustavslundsvägen 50 5th Floor
167 51, Bromma
+46 8 52 23 07 00
http://www.mobergderma.seGroup companies
Name | Category and Sector |
---|---|
Moberg Derma Incentives AB
| |
Pharmaceuticals: Major
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+140.66% | 94.69M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- MOB Stock
- Company Moberg Pharma AB